stage ivb lung cancer ajcc v8
Showing 1 - 25 of 81
Advanced Lung Adenocarcinoma, Advanced Lung Adenosquamous Carcinoma, Advanced Lung Non-Small Cell Carcinoma Trial in United
Recruiting
- Advanced Lung Adenocarcinoma
- +10 more
- Carboplatin
- +10 more
-
Phoenix, Arizona
- +98 more
Feb 2, 2023
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIA Lung Cancer AJCC v8 Trial in Los Angeles (Atezolizumab
Recruiting
- Lung Non-Small Cell Carcinoma
- +10 more
- Atezolizumab and Recombinant Human Hyaluronidase
- Survey Administration
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Jan 31, 2023
Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in
Recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +4 more
- Adenosine A2B Receptor Antagonist PBF-1129
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Feb 1, 2023
Lung Non-Squamous Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IIIC Lung Cancer AJCC v8 Trial in Canada,
Recruiting
- Lung Non-Squamous Non-Small Cell Carcinoma
- +5 more
- Carboplatin
- +2 more
-
Mobile, Alabama
- +1065 more
Jan 31, 2023
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Digestive System Carcinoma Trial in United
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +12 more
- Memantine
- +4 more
-
Tucson, Arizona
- +60 more
Jan 11, 2023
Metastatic Lung Non-Small Cell Carcinoma, Refractory Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer American Joint
Recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +4 more
- Necitumumab
- +4 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Jan 5, 2023
Leptomeningeal Tumor, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Tumor in the Brain Trial in United States
Recruiting
- Leptomeningeal Neoplasm
- +6 more
- Sapanisertib
- Telaglenastat Hydrochloride
-
Duarte, California
- +6 more
Dec 29, 2022
Metastatic Lung Non-Small Cell Squamous Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Stage IIIB Lung Cancer
Active, not recruiting
- Metastatic Lung Non-Small Cell Squamous Carcinoma
- +7 more
- Carboplatin
- +2 more
-
Los Angeles, California
- +9 more
Dec 17, 2022
Advanced Malignant Solid Tumor, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8
Recruiting
- Advanced Malignant Solid Neoplasm
- +28 more
- Capecitabine
- +16 more
-
Conroe, Texas
- +4 more
Dec 5, 2022
Anorexia, Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 Trial in Houston (Anamorelin Hydrochloride, Placebo,
Active, not recruiting
- Anorexia
- +8 more
- Anamorelin Hydrochloride
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Caregiver, Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8 Trial in Houston (Educational Intervention,
Recruiting
- Esophageal Carcinoma
- +16 more
- Educational Intervention
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Nov 11, 2022
Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Houston (drug,
Recruiting
- Extensive Stage Lung Small Cell Carcinoma
- +3 more
- Carboplatin
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Nov 8, 2022
National Cancer Institute "Cancer Moonshot Biobank"
Recruiting
- Acute Myeloid Leukemia
- +33 more
- Biospecimen Collection
- Medical Chart Review
-
Kingman, Arizona
- +99 more
Nov 3, 2022
Locally Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Trial in
Recruiting
- Locally Advanced Lung Non-Small Cell Carcinoma
- +12 more
- Computed Tomography
- Contrast Agent
-
New Brunswick, New Jersey
- +1 more
Nov 2, 2022
Extensive Stage Lung Small Cell Carcinoma, Metastatic Lung Small Cell Carcinoma, Recurrent Lung Small Cell Carcinoma Trial in
Recruiting
- Extensive Stage Lung Small Cell Carcinoma
- +5 more
- Atezolizumab
- Temozolomide
-
Indianapolis, Indiana
- +2 more
Oct 26, 2022
Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Carcinoma Trial in Houston
Active, not recruiting
- Advanced Colorectal Carcinoma
- +24 more
- Danvatirsen
- Durvalumab
-
Houston, TexasM D Anderson Cancer Center
Oct 20, 2022
Metastatic Non-Small Lung Cell Cancer, Recurrent Non-Small Lung Cell Cancer, Stage IV Lung Cancer AJCC v8 Trial in Atlanta
Recruiting
- Metastatic Non-Small Lung Cell Cancer
- +4 more
- Docetaxel
- +2 more
-
Atlanta, GeorgiaWinship Cancer Institute of Emory University
Oct 19, 2022
Advanced Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 Trial in Berkeley
Recruiting
- Advanced Lung Non-Small Cell Carcinoma
- +8 more
- Cobalamin
- +8 more
-
Birmingham, Alabama
- +349 more
Oct 18, 2022
Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma
Recruiting
- Clinical Stage 0 Cutaneous Melanoma AJCC v8
- +43 more
- Best Practice
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Oct 12, 2022
Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Houston
Recruiting
- Recurrent Lung Non-Small Cell Carcinoma
- +3 more
- Durvalumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 10, 2022
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Bladder Carcinoma
Recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +41 more
- Ipilimumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 11, 2022
Advanced Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8 Trial in Rochester
Recruiting
- Advanced Lung Non-Small Cell Carcinoma
- +7 more
- Exercise Counseling
- +5 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Oct 7, 2022
Small Cell Lung Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Winston-Salem (Gemcitabine,
Completed
- Small Cell Lung Carcinoma
- +3 more
- Gemcitabine
- Nivolumab
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Sep 6, 2022
Activating ALK Gene Mutation Negative, Activating EGFR Gene Mutation Negative, Activating ROS1 Gene Mutation Negative Trial in
Completed
- Activating ALK Gene Mutation Negative
- +7 more
- Counseling
- +2 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Sep 7, 2022